Haojun Yuan

Haojun Yuan

Auto-generated profile, based on publicly available information

Haojun Yuan

Mechanical and Electrical Engineering School, Zhejiang Fashion Institute of Technology, Ningbo, Zhejiang, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2025 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
XCXinyi Cao
Xinyi Cao
YDYingfen Dai
Yingfen Dai
HYHaojun Yuan
Haojun Yuan
ZZZhikang Zhang
Zhikang Zhang
PYPanhui Yang
Panhui Yang
QJQinghui Jin
Qinghui Jin
Hybridoma cell screening is crucial for the production of monoclonal antibodies; however, traditional screening methods are often time-consuming and reliant on antigen-antibody labeling. This study introduces a label-free, single-cell, multi-frequency impedance detection system that innovatively utilizes impedance spectra as a novel physical parameter to differentiate between various hybridoma and myeloma cell types. The sensing device integrates dual-funnel structures with coplanar electrodes, which are respectively utilized for cell capture and impedance measurement. By optimizing the excitation voltage and flow rate, the system effectively reduces measurement errors. The sensing device was validated using polystyrene microbeads of different diameters, yielding coefficients of variation (CV) of 0.0241% and 0.0132%, indicating high measurement stability and repeatability. The system was further validated with two types of hybridoma cells (E5, CD2) and myeloma cells (SP20), and impedance data were analyzed using orthogonal partial least squares discriminant analysis (OPLS-DA) via SIMCA 14.5 software, achieving a model prediction accuracy of 0.974. The results demonstrate that the system can stably and accurately measure cell impedance spectra, and that impedance spectra, as a label-free parameter, can effectively distinguish between different types of hybridoma and myeloma cells, showing great potential for hybridoma cell sorting.

5 May 2025 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
HYHaojun Yuan
Haojun Yuan
WGWanlei Gao
Wanlei Gao
PYPing Yang
Ping Yang
XCXinyi Cao
Xinyi Cao
YWYangbo Wu
Yangbo Wu
QJQinghui Jin
Qinghui Jin
Point-of-care testing (PoCT) method is suitable for rapid detection and daily monitoring of various acute diseases, which can effectively improve patients’ survival rates. Current lateral flow assay-based PoCT systems, with insufficient sensitivity, cannot meet the simultaneous detection requirements of rare multiple biomarkers. Therefore, we developed an electrochemiluminescence (ECL) microchip based PoCT system, realizing rapid and highly sensitive detection of multiple biomarkers. This microchip incorporated specific aptamer probes assembled working electrode array and a shared counting electrode, thus forming a two -electrode based detection units for initiating Ru(bpy)32+/TPrA based ECL reaction. Integrated with photomultiplier tube (PMT) and a constant transient potential model, the PoCT system was capable of sensitively detecting three Acute Myocardial Infarction (AMI) biomarkers-cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase MB (CK - MB)-on a single microchip within just 20 min. The system exhibited an excellent detection limit of 0.25 pg/mL, 0.05 pg/mL, and 5 pg/mL for cTnI, Myo, and CK-MB, in a wide linear range of 1 pg/mL-1 μ g/mL, 0.1 pg/mL-10 ng/mL, and 10 pg/mL-1 μ g/mL, respectively. Furthermore, the analysis of AMI biomarkers in mixture and serum samples was conducted with high sensitivity and specificity, as well as low cross-talk.The platform synergized high sensitivity of ECL with the multiplexing of micro-chip, thereby holding tremendous potential for application in PoCT.